Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab

Purpose: In patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), the standard of care is concurrent chemoradiation (CRT) followed by consolidative immunotherapy with durvalumab. Pneumonitis is a known adverse event of both radiation therapy and immune checkpoint inhibitor...

Full description

Bibliographic Details
Main Authors: Brett H. Diamond, MD, Neel Belani, MD, Rebecca Masel, MD, Kathryn DeCarli, MD, MBE, Thomas DiPetrillo, MD, Jaroslaw T. Hepel, MD, Christopher G. Azzoli, MD, Humera Khurshid, MD, Abbas Abbas, MD, Paul P. Koffer, MD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422002366

Internet

http://www.sciencedirect.com/science/article/pii/S2452109422002366

Similar Items